Efficacy Insights

Efficacy analyses in early-phase oncology development often require rapid exploration of biomarker-defined patient subgroups. Traditional static TLF workflows can limit efficient collaboration between clinical and biometrics teams.

This interactive workspace enables flexible exploration of PFS, OS, ORR, and DoR endpoints through dynamic statistical visualizations and subgroup analyses.